Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Food and Drug Administration’s (FDA) has authorized the emergency use of mRNA-1273, Moderna’s vaccine against COVID-19 in individuals ...
Pfizer Inc. and BioNTech SE announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine (BNT162b2), against COVID-19. This constitutes ...
COVID-19’s outbreak has coincided with investments flooding into nanotech-based healthcare companies, according to Pitchbook‘s latest data. The investment monitoring platform reported that the sector benefited by £1.7bn in 2020 – £1.1bn more than the year ...
Popular Posts
